Inhibitory potential of probiotic spore formers grown as mono- and mix-cultures under conditions of different nutrient availability
DOI:
https://doi.org/10.14739/mmt.2024.4.311797Keywords:
A. clausii, H. coagulans, B. subtilis, S. aureus, E. coli, P. aeruginosa, inhibitory activity, dissemination ability, co-cultivation, nutrient depletion, starvationAbstract
In many clinical cases, the use of probiotic microorganisms is a safer alternative to antibiotic therapy. Spore-forming probiotics, due to their high resistance to damaging environmental factors, stand out among other beneficial microorganisms and, therefore, deserve special attention. Determining the conditions that enhance the inhibitory potential of probiotic bacilli is an important step towards increasing their effectiveness against pathogenic bacteria and pathobionts.
The aim of this study was to determine whether the inhibitory potential of spore-forming probiotic species: Alkalihalobacillus clausii (previously known as B. clausii), Heyndrickxia coagulans (formerly B. coagulans) and B. subtilis increases under conditions of co-cultivation or nutrient depletion (starvation).
Materials and methods. The commercial strains of bacilli from three probiotic preparations: Enterogermina (A. clausii), Lactovit forte (H. coagulans) and Subalin (B. subtilis) were used in this study. The ability of mono- and mix-cultures of the studied probiotic species cultured on conventional and semi-starvation nutrient media to affect the growth of indicator bacteria-pathobionts (Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa) was investigated by the agar block method (using 1.5 % nutrient agar) and the spot-on-lawn assay with wells (using 0.7 % nutrient agar).
Results. Inhibitory activity against indicator bacteria-pathobionts was characteristic of both mono- and mixed probiotic test cultures. Using the agar block method, probiotic monocultures grown on nutritive agar demonstrated moderate inhibitory activity against S. aureus and P. aeruginosa, but weak inhibitory activity against E. coli. Probiotic monocultures grown on “semi-starvation” agar and mix-cultures regardless of the culture medium showed pronounced inhibitory activity against S. aureus and P. aeruginosa, but moderate inhibitory activity against E. coli. Co-cultivation and cultivation on semi-starved media were accompanied by an increase in the number of isolated colonies of probiotic bacilli (disseminates) in the transparent zone of no growth and the pathobiont growth zone. Using spot-on-lawn assay revealed moderate inhibition of staphylococcus growth by both mono- and mixed probiotic cultures, regardless of their cultivation conditions. However, the inhibition indicators of probiotic mix-cultures were statistically significantly higher than those of monocultures. The inhibitory activity of probiotic monocultures against E. coli and P. aeruginosa was moderate, while probiotic mix-cultures had a pronounced inhibitory effect on these gram-negative bacteria.
Conclusions. The inhibitory activity and dissemination ability of spore-forming probiotic species: A. clausii, H. coagulans and B. subtilis increases under conditions of co-cultivation or nutrient depletion (starvation). The demonstrated effect of increasing the inhibitory potential of probiotic spore-forming bacteria by co-cultivation and application of nutrient depletion conditions requires further study and clarification of the underlying molecular mechanisms.
References
Ghuneim LA, Raghuvanshi R, Neugebauer KA, Guzior DV, Christian MH, Schena B, et al. Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection. ISME J. 2022;16(9):2065-75. doi: https://doi.org/10.1038/s41396-022-01252-5
Liu X, Liu F, Ding S, Shen J, Zhu K. Sublethal Levels of Antibiotics Promote Bacterial Persistence in Epithelial Cells. Adv Sci (Weinh). 2020;7(18):1900840. doi: https://doi.org/10.1002/advs.201900840
Ranjan A. The use of probiotics, prebiotics, and synbiotics as an alternative to antibiotics. In: Alternatives to Antibiotics. Singapore: Springer Nature Singapore; 2022. p. 449-65. doi: https://doi.org/10.1007/978-981-19-1854-4_18
Zhu J, Chen Y, Imre K, Arslan-Acaroz D, Istanbullugil FR, Fang Y, et al. Mechanisms of probiotic Bacillus against enteric bacterial infections. One Health Adv. 2023;1(1). doi: https://doi.org/10.1186/s44280-023-00020-0
Aponte M, Murru N, Shoukat M. Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective. Front Microbiol. 2020;11:562048. doi: https://doi.org/10.3389/fmicb.2020.562048
Das TK, Pradhan S, Chakrabarti S, Mondal KC, Ghosh K. Current status of probiotic and related health benefits. Applied Food Research. 2022;2(2):100185. doi: https://doi.org/10.1016/j.afres.2022.100185
Elshaghabee FM, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives. Front Microbiol. 2017;8. doi: https://doi.org/10.3389/fmicb.2017.01490
Lee NK, Kim WS, Paik HD. Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier. Food Sci Biotechnol. 2019;28(5):1297-305. doi: https://doi.org/10.1007/s10068-019-00691-9
Soares MB, Almada CN, Pereira EP, Ferreira BM, Balthazar CF, Khorshidian N, et al. Review - Sporeforming probiotic bacteria: Characteristics, health benefits, and technological aspects for their applications in foods and beverages. Trends Food Sci Technol. 2023;138:453-69. doi: https://doi.org/10.1016/j.tifs.2023.06.029
Ghelardi E, Abreu y Abreu AT, Marzet CB, Álvarez Calatayud G, Perez M, Moschione Castro AP. Current Progress and Future Perspectives on the Use of Bacillus clausii. Microorganisms. 2022;10(6):1246. doi: https://doi.org/10.3390/microorganisms10061246
Santacroce L, Charitos IA, Bottalico L. A successful history: probiotics and their potential as antimicrobials. Expert Rev Anti Infect Ther. 2019;17(8):635-45. doi: https://doi.org/10.1080/14787210.2019.1645597
Mazkour S, Shekarforoush SS, Basiri S. The effects of supplementation of Bacillus subtilis and Bacillus coagulans spores on the intestinal microflora and growth performance in rat. Iran J Microbiol. 2019;11(3):260-6. doi: https://doi.org/10.18502/ijm.v11i3.133
Management Board members, Executive Director, Operational Management. Qualified presumption of safety (QPS) [Internet]. European Food Safety Authority. 2024 [cited 2024 Nov 16]. Available from: https://www.efsa.europa.eu/en/topics/topic/qualified-presumption-safety-qps
Cao J, Yu Z, Liu W, Zhao J, Zhang H, Zhai Q, et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. J Funct Foods. 2020;64(103643):103643. doi: https://doi.org/10.1016/j.jff.2019.103643
GRAS Notices (GRN) No. 660 Bacillus coagulans GBI-30, 6086 spores. Fda.gov. [cited 2024 Nov 16]. Available from: https://www.fda.gov/files/food/published/GRAS-Notice-000660---Bacillus-coagulans-GBI-30--6086.pdf
Sorokulova I. Modern Status and Perspectives of Bacillus Bacteria as Probiotics. J Probiotics Health. 2013;1(4): 1000e106. doi: https://doi.org/10.4172/2329-8901.1000e106
Zhang L, Yi H. Potential antitumor and anti-inflammatory activities of an extracellular polymeric substance (EPS) from Bacillus subtilis isolated from a housefly. Sci Rep. 2022;12(1):1383. doi: https://doi.org/10.1038/s41598-022-05143-9
Fijan S, Fijan T, Connil N. Overview of Probiotic Strains of Weizmannia coagulans, Previously Known as Bacillus coagulans, as Food Supplements and Their Use in Human Health. Applied Microbiology. 2023;3(3):935-47. doi: https://doi.org/10.3390/applmicrobiol3030064
Su Y, Liu C, Fang H, Zhang D. Bacillus subtilis: a universal cell factory for industry, agriculture, biomaterials and medicine. Microb Cell Fact. 2020;19(1):173. doi: https://doi.org/10.1186/s12934-020-01436-8
Puvanasundram P, Chong CM, Sabri S, Yusoff MdS, Karim M. Multi-strain probiotics: Functions, effectiveness and formulations for aquaculture applications. Aquac Rep. 2021;21:100905. doi: https://doi.org/10.1016/j.aqrep.2021.100905
Ouwehand AC, Invernici MM, Furlaneto FAC, Messora MR. Effectiveness of Multistrain Versus Single-strain Probiotics: Current Status and Recommendations for the Future. J Clin Gastroenterol. 2018;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S35-S40. doi: https://doi.org/10.1097/MCG.0000000000001052
McFarland LV, Huang Y, Wang L, Malfertheiner P. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylorieradication and prevention of adverse events. United European Gastroenterol J. 2016;4(4):546-61. doi: https://doi.org/10.1177/2050640615617358
Knysh OV. Bifidogenic properties of cell-free extracts derived from probiotic strains of Bifidobacterium bifidum and Lactobacillus reuteri. Regulatory Mechanisms in Biosystems. 2019;10(1):124-8. doi: https://doi.org/10.15421/021919
Fijan S, Šulc D, Steyer A. Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli. Int J Environ Res Public Health. 2018;15(7):1539. doi: https://doi.org/10.3390/ijerph15071539
Bernatek M, Żukiewicz-Sobczak W, Lachowicz-Wiśniewska S, Piątek J. Factors Determining Effective Probiotic Activity: Evaluation of Survival and Antibacterial Activity of Selected Probiotic Products Using an "In Vitro" Study. Nutrients. 2022;14(16):3323. doi: https://doi.org/10.3390/nu14163323
Hong-Thao PT, Mai-Linh NV, Hong-Lien NT, Van Hieu N. Biological Characteristics and Antimicrobial Activity of Endophytic Streptomyces sp. TQR12-4 Isolated from Elite Citrus nobilis Cultivar Ham Yen of Vietnam. Int J Microbiol. 2016;2016:7207818. doi: http://doi.org/10.1155/2016/7207818
Cao Y, Pi H, Chandrangsu P, Li Y, Wang Y, Zhou H, et al. Antagonism of Two Plant-Growth Promoting Bacillus velezensis Isolates Against Ralstonia solanacearum and Fusarium oxysporum. Sci Rep. 2018;8(1):4360. doi: https://doi.org/10.1038/s41598-018-22782-z
Chechet OM, Kovalenko VL, Horbatyuk OI, Gaidei OS, Kravtsova OL, Andriyashchuk VO, et al. Antagonistic properties of a probiotic preparation containing bacteria of the genera Bacillus and Enterococcus. Regulatory Mechanisms in Biosystems. 2022;13(4):362-6. doi: https://doi.org/10.15421/022247
Bartolini M, Grau R. Assessing Different Ways of Bacillus subtilis Spreading over Abiotic Surfaces. Bio Protoc. 2019;9(22):e3425. doi: https://doi.org/10.21769/bioprotoc.3425
Rütschlin S, Böttcher T. Inhibitors of Bacterial Swarming Behavior. Chemistry. 2020;26(5):964-79. doi: https://doi.org/10.1002/chem.201901961
Jeckel H, Jelli E, Hartmann R, Singh PK, Mok R, Totz JF, et al. Learning the space-time phase diagram of bacterial swarm expansion. Proc Natl Acad Sci U S A. 2019;116(5):1489-94. doi: https://doi.org/10.1073/pnas.1811722116
Knysh OV, Martynov AV, Pokhyl SI, Skliar NI. The behavior of the Bacillus probiotic species under conditions of co-cultivation. Modern medical technology. 2023;(4):59-69. doi: https://doi.org/10.34287/mmt.4(59).2023.8
Darbandi A, Asadi A, Mahdizade Ari M, Ohadi E, Talebi M, Halaj Zadeh M, et al. Bacteriocins: Properties and potential use as antimicrobials. J Clin Lab Anal. 2021;36(1):e24093. doi: https://doi.org/10.1002/jcla.24093
Bartel LC, Abrahamovich E, Mori C, López AC, Alippi AM. Bacillus and Brevibacillus strains as potential antagonists of Paenibacillus larvae and Ascosphaera apis. J Apic Res. 2018;58(1):117-32. doi: https://doi.org/10.1080/00218839.2018.1495439
Bhattacharya A, Pak HT, Bashey F. Plastic responses to competition: Does bacteriocin production increase in the presence of nonself competitors? Ecol Evol. 2018;8(14):6880-8. doi: https://doi.org/10.1002/ece3.4203
Gonzalez D, Mavridou DA. Making the Best of Aggression: The Many Dimensions of Bacterial Toxin Regulation. Trends Microbiol. 2019;27(11):897-905. doi: https://doi.org/10.1016/j.tim.2019.05.009
Ghazaei C. Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria. J Clin Res Paramed Sci. 2022;11(2). doi: https://doi.org/10.5812/jcrps-130208
Knysh O, Martynov A. Nisin: Prerequisites and Prospects for Application in the Medical Field. Galician medical journal. 2023;30(1):E202316. doi: https://doi.org/10.21802/gmj.2023.1.6
Soltani S, Hammami R, Cotter PD, Rebuffat S, Said LB, Gaudreau H, et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev. 2021;45(1):fuaa039. doi: https://doi.org/10.1093/femsre/fuaa039
Kern L, Abdeen SK, Kolodziejczyk AA, Elinav E. Commensal inter-bacterial interactions shaping the microbiota. Curr Opin Microbiol. 2021;63:158-71. doi: https://doi.org/10.1016/j.mib.2021.07.011
Nie R, Zhu Z, Qi Y, Wang Z, Sun H, Liu G. Bacteriocin production enhancing mechanism of Lactiplantibacillus paraplantarum RX-8 response to Wickerhamomyces anomalus Y-5 by transcriptomic and proteomic analyses. Front Microbiol. 2023;14:1111516. doi: https://doi.org/10.3389/fmicb.2023.1111516
Gutiérrez-Cortés C, Suarez H, Buitrago G, Nero LA, Todorov SD. Enhanced Bacteriocin Production by Pediococcus pentosaceus 147 in Co-culture With Lactobacillus plantarum LE27 on Cheese Whey Broth. Front Microbiol. 2018;9:2952. doi: https://doi.org/10.3389/fmicb.2018.02952
